Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
AR-13324
print preview
bookmark
share with colleague
General Information
Company
Aerie Pharmaceuticals Inc.
Description
Dual inhibitor of Rho kinase and the norepinephrine transporter
Molecular Target
Rho kinase
;
Norepinephrine transporter
Mechanism of Action
Latest Stage of Development
Phase II
Indication
Glaucoma
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy